Medication adherence in Inflammatory Bowel Disease patients: a New Zealand-wide inter-disciplinary investigation
Professor Michael Schultz Professor and Rhiannon Braund Kristina Aluzaite
Inflammatory Bowel Disease (IBD) is a chronic disease of the gut comprising Crohn’s Disease, Ulcerative Colitis and IBD-unclassified. Therapy includes a life-long medication regimen and constant monitoring; hence, medication adherence (MA) is of particular importance. Further, New Zealand has one of the highest national burdens of IBD in the world, with about 21,000 sufferers. Using nationwide MoH/PHARMAC datasets on IBD medications dispensed and hospitalisation events for the patients, Obren’s PhD will assess medication adherence (MA) in IBD patients and investigate if MA levels are associated with hospitalisation events. Obren will also seek to identify other factors associated with IBD such as age, gender, ethnicity, socio-economic status and geographical location. Obren will repeat these analyses using data specific to the Southern DHB. More so, Obren will analyse public policies on improving MA with a view to recommending ways they might be optimised to meet the needs of IBD patients. Obren’s presentation will introduce his work in further detail.
All University of Otago and Southern District Health Board staff and students are welcome to attend via Zoom.
Zoom ID: 785276986
|Date||Friday, 16 April 2021|
|Time||1:00pm - 2:00pm|
|Event Category||Health Sciences|
|Location||9th floor Seminar Room and via zoom, Dunedin Public Hospital, Dunedin|
|Contact Name||Amanda Buchanan|